Hirokazu Kanegane - Concepedia

Author

Hirokazu Kanegane

Tokyo Medical and Dental University ORCID

Also Known As

Anne Durandy, H KANEGANE, H Kanegane, H. KANEGANE, H. Kanegane, HIROKAZU KANEGANE, HIrokazu Kanegane, Hirokazu KANEGANE, Hirokazu Kanegane, Kanegane

544

Publications

14.6K

Citations

H-Index

209

Concepts

All Affiliations

Tokyo Medical and Dental University University of Toyama The University of Tokyo Tohoku Medical and Pharmaceutical University Kanazawa University

About

Hirokazu Kanegane is an author at Tokyo Medical and Dental University specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	116	6.1K
2	Health Sciences	12	13	418
3	Allergy	10	10	916
4	Public Health	4	4	193
5	Engineering	1	1	62

Hirokazu Kanegane

208

Publications

12.1K

Citations

H-Index

Page 1

	Year	Citations
Clinical and virologic characteristics of chronic active Epstein-Barr virus infection Hiroshi Kimura, Yo Hoshino, Hirokazu Kanegane, Blood	2001	425
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects Charlotte Schwab, Annemarie Gabrysch, Peter Olbrich, Journal of Allergy and Clinical Immunology Clinical ImmunologyAllergyLymphocyte DevelopmentMedicineImmunodeficiencies	2018	423
The landscape of somatic mutations in Down syndrome–related myeloid disorders Kenichi Yoshida, Tsutomu Toki, Yusuke Okuno, Nature Genetics Down SyndromeSomatic VariantSomatic MutationsGenetic DisorderGenetics	2013	381
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency) Jana Pachlopnik Schmid, Danielle Canioni, Despina Moshous, Blood	2010	364
X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease Claire Booth, Kimberly Gilmour, Paul Veys, Blood	2010	309
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study Federica Barzaghi, Laura Amaya, Bénédicte Neven, Journal of Allergy and Clinical Immunology	2017	301
Report of a WHO Scientific Group Takeshi Futatani, Hirokazu Kanegane, Toshio Miyawaki Clinical & Experimental Immunology Science StudyScientific LiteracyScientific IntegrityBiostatisticsScience And Technology Studies	1995	263
XIAP Restricts TNF- and RIP3-Dependent Cell Death and Inflammasome Activation Monica Yabal, Nicole Müller, Heiko Adler, Cell Reports	2014	261
Prognostic Factors for Chronic Active Epstein‐Barr Virus Infection Hiroshi Kimura, Tsuneo Morishima, Hirokazu Kanegane, The Journal of Infectious Diseases	2003	244
Activation of naive and memory T cells by interleukin-15 Hirokazu Kanegane, Giovanna Tosato Blood	1996	174

Page 1